Compounds > cabergoline
Page last updated: 2024-08-23

cabergoline and Puerperal Disorders

cabergoline has been researched along with Puerperal Disorders in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Hayashi, T; Higuchi, Y; Hirayama, A; Ichibori, Y; Iwai, S; Makino, N; Minamiguchi, H; Mitake, A; Mori, N; Shiba, M; Shibuya, Y1
Araujo Júnior, E; Carvalho, JS; Carvalho, RC; Costa Carvalho, FH; Feitosa, FE; Melo, MA; Peixoto, AB1
Fett, JD1
Bouma, BJ; de Jong, JS; Rietveld, K; van Lochem, LT1
Peregrin Abad, E; Salinas Botrán, A; Urgelés Puértolas, D1
Auriemma, RS; Colao, A; Di Sarno, A; Gasperi, M; Grasso, LF; Guerra, E; Perone, Y; Pivonello, R1
Armentano, G; Bracco, PL; Pellegrini, A; Sugliano, GC; Tornatore, GP1

Trials

1 trial(s) available for cabergoline and Puerperal Disorders

ArticleYear
[Cabergoline in the inhibition of lactogenesis and suppression of lactopoiesis].
    Minerva ginecologica, 1997, Volume: 49, Issue:10

    Topics: Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Infant, Newborn; Lactation; Pregnancy; Prolactin; Puerperal Disorders

1997

Other Studies

6 other study(ies) available for cabergoline and Puerperal Disorders

ArticleYear
Peripartum Cardiomyopathy with the Cardiac Function Restored by Cabergoline.
    Internal medicine (Tokyo, Japan), 2023, Jul-15, Volume: 62, Issue:14

    Topics: Adult; Cabergoline; Cardiomyopathies; Cesarean Section; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders

2023
Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome.
    Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2016, Volume: 38, Issue:6

    Topics: Adolescent; Cabergoline; Cardiomyopathies; Dopamine Agonists; Ergolines; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Puerperal Disorders

2016
Cabergoline in the Treatment of Peripartum Cardiomyopathy.
    Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2016, Volume: 38, Issue:8

    Topics: Cabergoline; Cardiomyopathies; Dopamine Agonists; Female; Humans; Peripartum Period; Pregnancy; Puerperal Disorders

2016
Rapid left ventricular recovery after cabergoline treatment in a patient with peripartum cardiomyopathy.
    European journal of heart failure, 2009, Volume: 11, Issue:2

    Topics: Adult; Cabergoline; Cardiomyopathies; Echocardiography; Ergolines; Female; Humans; Natriuretic Peptide, Brain; Peptide Fragments; Pregnancy; Prolactin; Puerperal Disorders; Ventricular Dysfunction, Left

2009
[Postpartum psychosis associated with cabergoline].
    Medicina clinica, 2013, Jan-05, Volume: 140, Issue:1

    Topics: Adult; Antipsychotic Agents; Cabergoline; Cesarean Section; Dopamine Agonists; Ergolines; Female; Hallucinations; Humans; Lactation; Postoperative Complications; Pregnancy; Pregnancy Complications; Pregnancy, Twin; Psychomotor Agitation; Psychotic Disorders; Puerperal Disorders; Risperidone; Sleep Initiation and Maintenance Disorders

2013
Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation.
    The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:1

    Topics: Adult; Antineoplastic Agents; Breast Feeding; Cabergoline; Data Collection; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Lactation; Observation; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma; Puerperal Disorders; Recurrence; Time Factors

2013